Anavex Investors Have Until November 30 to Seek Lead Plaintiff Role

Investors in Anavex Life Sciences Corp. have until November 30, 2026, to seek the lead plaintiff role in a securities fraud class action, according to a notice from Glancy Prongay Wolke & Rotter LLP.